Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:37 pm Purchase |
2025-04-15 | 13G | Mural Oncology plc MURA |
Soleus Capital Master Fund, L.P. | 1,079,927 6.300% |
1,079,927 (New Position) |
Filing History |
| 2025-04-15 4:46 pm Purchase |
2025-04-15 | 13D | ESSA Pharma Inc. EPIX |
Soleus Capital Master Fund, L.P. | 2,262,026 5.100% |
2,262,026 (New Position) |
Filing History |
| 2025-04-11 7:30 pm Sale |
2025-04-11 | 13D | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 4,801,375 10.400% |
-387,501 (-7.47%) |
Filing History |
| 2025-04-01 5:00 pm Purchase |
2025-03-31 | 13G | NovoCure Limited NVCR |
Soleus Capital Master Fund, L.P. | 5,521,414 5.000% |
5,521,414 (New Position) |
Filing History |
| 2025-03-28 5:09 pm Purchase |
2025-03-26 | 13G | STAAR Surgical Company STAA |
Soleus Capital Master Fund, L.P. | 2,562,893 5.200% |
2,562,893 (New Position) |
Filing History |
| 2025-03-19 5:00 pm Purchase |
2025-03-18 | 13G | Praxis Precision Medicines, Inc. PRAX |
Soleus Capital Master Fund, L.P. | 1,017,740 5.000% |
1,017,740 (New Position) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 1,130,679 6.400% |
195,891 (+20.96%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 12,484,876 9.900% |
645,000 (+5.45%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Capital Master Fund, L.P. | 1,494,420 9.960% |
507,324 (+51.40%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Celcuity Inc. CELC |
Soleus Capital Master Fund, L.P. | 3,872,184 9.900% |
1,248,294 (+47.57%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 8,142,500 9.600% |
1,918,956 (+30.83%) |
Filing History |
| 2025-02-11 4:00 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 3,350,692 7.300% |
1,925,058 (+135.03%) |
Filing History |
| 2025-01-22 5:15 pm Purchase |
2025-01-21 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 739,060 5.200% |
101,362 (+15.89%) |
Filing History |
| 2024-11-14 3:36 pm Sale |
2024-09-30 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 637,698 4.500% |
-134,002 (-17.36%) |
Filing History |
| 2024-11-14 3:35 pm Purchase |
2024-09-30 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 11,839,876 8.900% |
2,876,876 (+32.10%) |
Filing History |
| 2024-11-14 3:35 pm Sale |
2024-09-30 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 1,000 0.000% |
-642,206 (-99.84%) |
Filing History |
| 2024-11-14 3:34 pm Sale |
2024-09-30 | 13G | VYNE Therapeutics Inc. VYNE |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-703,868 (Position Closed) |
Filing History |
| 2024-11-14 3:33 pm Purchase |
2024-09-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 934,788 5.300% |
934,788 (New Position) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 3,005,943 6.800% |
410,128 (+15.80%) |
Filing History |
| 2024-11-14 3:30 pm Purchase |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Soleus Capital Master Fund, L.P. | 6,223,544 7.300% |
2,882,424 (+86.27%) |
Filing History |